Publications
126 found
Show per page
Baumann, Sandra, Sewing, Lilian, Traechslin, Cyril, Verhagen-Kamerbeek, Wilma, Grize, Leticia, Kraenzlin, Marius, & . (2025). Serum Pentosidine in Relation to Obesity in Patients with Type 2 Diabetes and Healthy Controls [Journal-article]. Calcified Tissue International, 116(1). https://doi.org/10.1007/s00223-024-01338-6
Baumann, Sandra, Sewing, Lilian, Traechslin, Cyril, Verhagen-Kamerbeek, Wilma, Grize, Leticia, Kraenzlin, Marius, & . (2025). Serum Pentosidine in Relation to Obesity in Patients with Type 2 Diabetes and Healthy Controls [Journal-article]. Calcified Tissue International, 116(1). https://doi.org/10.1007/s00223-024-01338-6
Thierry, Susanne, Peterson, Caspar Joyce, Pfammatter, Stéphanie, Tardio, Patricia Arroyo, , Delko, Tarik, Iten, Vasco, Zuern, Christine S., Kühne, Michael, Epstein, Michael, Othman, Alaa, Zamboni, Nicola, Reinisch, Isabel, Ghosh, Adhideb, Wolfrum, Christian, & Seelig, Eleonora. (2025). Short-term Metformin Protects Against Glucocorticoid-Induced Toxicity in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial [Journal-article]. Diabetes Care, 48(5), 719–727. https://doi.org/10.2337/dc24-2039
Thierry, Susanne, Peterson, Caspar Joyce, Pfammatter, Stéphanie, Tardio, Patricia Arroyo, , Delko, Tarik, Iten, Vasco, Zuern, Christine S., Kühne, Michael, Epstein, Michael, Othman, Alaa, Zamboni, Nicola, Reinisch, Isabel, Ghosh, Adhideb, Wolfrum, Christian, & Seelig, Eleonora. (2025). Short-term Metformin Protects Against Glucocorticoid-Induced Toxicity in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial [Journal-article]. Diabetes Care, 48(5), 719–727. https://doi.org/10.2337/dc24-2039
, Eastell, Richard, Pierroz, Dominique D, Lane, Nancy E, Al-Daghri, Nasser, Suzuki, Atsushi, Napoli, Nicola, Mithal, Ambrish, Chakhtoura, Marlene, Fuleihan, Ghada El-Hajj, & Ferrari, Serge. (2023). Biochemical Markers of Bone Fragility in Patients With Diabetes [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 108(10), e923–e936. https://doi.org/10.1210/clinem/dgad255
, Eastell, Richard, Pierroz, Dominique D, Lane, Nancy E, Al-Daghri, Nasser, Suzuki, Atsushi, Napoli, Nicola, Mithal, Ambrish, Chakhtoura, Marlene, Fuleihan, Ghada El-Hajj, & Ferrari, Serge. (2023). Biochemical Markers of Bone Fragility in Patients With Diabetes [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 108(10), e923–e936. https://doi.org/10.1210/clinem/dgad255
Monnerat, Sophie, Refardt, Julie, Potasso, Laura, , & Christ-Crain, Mirjam. (2023). An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 108(10), e1027–e1033. https://doi.org/10.1210/clinem/dgad238
Monnerat, Sophie, Refardt, Julie, Potasso, Laura, , & Christ-Crain, Mirjam. (2023). An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 108(10), e1027–e1033. https://doi.org/10.1210/clinem/dgad238
Ferrari, Serge, & . (2023). Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss Medical Weekly, 153(4). https://doi.org/10.57187/smw.2023.40075
Ferrari, Serge, & . (2023). Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss Medical Weekly, 153(4). https://doi.org/10.57187/smw.2023.40075
Jung, Ruedi, Zürcher, Simeon J., Schindera, Christina, Eser, Prisca, , Schai, Anna, Braun, Julia, Deng, Wei Hai, Hebestreit, Helge, Neuhaus, Cornelia, Schaeff, Jonathan, Rueegg, Corina S., von der Weid, Nicolas X., & Kriemler, Susi. (2023). Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit). International Journal of Cancer, 152(2), 162–171. https://doi.org/10.1002/ijc.34234
Jung, Ruedi, Zürcher, Simeon J., Schindera, Christina, Eser, Prisca, , Schai, Anna, Braun, Julia, Deng, Wei Hai, Hebestreit, Helge, Neuhaus, Cornelia, Schaeff, Jonathan, Rueegg, Corina S., von der Weid, Nicolas X., & Kriemler, Susi. (2023). Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit). International Journal of Cancer, 152(2), 162–171. https://doi.org/10.1002/ijc.34234
De Geyter, C., Matt, L., De Geyter, I., Moffat, R., & (2023). In infertile women with subclinical hypothyroidism, with or without thyroid peroxidase antibodies, serum TSH during pregnancy follows preconception values and thyroid hormones remain stable. Human Reproduction Open, 2023(4). https://doi.org/10.1093/hropen/hoad038
De Geyter, C., Matt, L., De Geyter, I., Moffat, R., & (2023). In infertile women with subclinical hypothyroidism, with or without thyroid peroxidase antibodies, serum TSH during pregnancy follows preconception values and thyroid hormones remain stable. Human Reproduction Open, 2023(4). https://doi.org/10.1093/hropen/hoad038
R Charlier SH, , Jick SS, R, & Becker C. (2022). Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study. Cardiovascular Diabetology, 21(1), 2. https://doi.org/10.1186/s12933-021-01432-1
R Charlier SH, , Jick SS, R, & Becker C. (2022). Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study. Cardiovascular Diabetology, 21(1), 2. https://doi.org/10.1186/s12933-021-01432-1
Bischof E, Schwab FD, Georgescu Margarint EL, Montavon C, Zünti I, Schollbach A, Schötzau A, Hirschmann A, Landin J, , Christian K, & Vetter M. (2022). Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience. Bone Reports, 16, 101160. https://doi.org/10.1016/j.bonr.2021.101160
Bischof E, Schwab FD, Georgescu Margarint EL, Montavon C, Zünti I, Schollbach A, Schötzau A, Hirschmann A, Landin J, , Christian K, & Vetter M. (2022). Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience. Bone Reports, 16, 101160. https://doi.org/10.1016/j.bonr.2021.101160
Sewing L, Potasso L, Baumann S, Schenk D, Gazozcu F, Lippuner K, Kraenzlin M, Zysset P, & . (2022). Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes. Journal of Bone and Mineral Research, 37(5), 837–847. https://doi.org/10.1002/jbmr.4517
Sewing L, Potasso L, Baumann S, Schenk D, Gazozcu F, Lippuner K, Kraenzlin M, Zysset P, & . (2022). Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes. Journal of Bone and Mineral Research, 37(5), 837–847. https://doi.org/10.1002/jbmr.4517
Jehle‐kunz, Sigrid, Häuselmann, Hans-Jörg, Keschawarzi, Mitra, Lamy, Olivier, Luzuy, Franck, Marcoli, Natalie, , Uebelhart, Brigitte, & Wiedersheim, Peter. (2022). Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey. Healthcare (Switzerland), 10(2). https://doi.org/10.3390/healthcare10020295
Jehle‐kunz, Sigrid, Häuselmann, Hans-Jörg, Keschawarzi, Mitra, Lamy, Olivier, Luzuy, Franck, Marcoli, Natalie, , Uebelhart, Brigitte, & Wiedersheim, Peter. (2022). Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey. Healthcare (Switzerland), 10(2). https://doi.org/10.3390/healthcare10020295
Paccou J., Tsourdi E., , Palermo A., Pepe J., Body J.-J., & Zillikens M.C. (2022). Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS). Bone, 154. https://doi.org/10.1016/j.bone.2021.116236
Paccou J., Tsourdi E., , Palermo A., Pepe J., Body J.-J., & Zillikens M.C. (2022). Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS). Bone, 154. https://doi.org/10.1016/j.bone.2021.116236
Potasso L, Potasso L, Refardt J., , & Christ-Crain M. (2022). Effect of hyponatremia normalization on osteoblast function in patients with SIAD. European Journal of Endocrinology, 186(1), 1–8. https://doi.org/10.1530/eje-21-0604
Potasso L, Potasso L, Refardt J., , & Christ-Crain M. (2022). Effect of hyponatremia normalization on osteoblast function in patients with SIAD. European Journal of Endocrinology, 186(1), 1–8. https://doi.org/10.1530/eje-21-0604
Vavanikunnel, J., Sewing, L., Triantafyllidou, M., Steighardt, A., Baumann, S., Egger, A., Grize, L., Felix, B., Kraenzlin, M., Henzen, C., & (2022). Determinants of low bone turnover in type 2 diabetes-the role of PTH. Calcif Tissue Int, 111(6), 587–596. https://doi.org/10.1007/s00223-022-01022-7
Vavanikunnel, J., Sewing, L., Triantafyllidou, M., Steighardt, A., Baumann, S., Egger, A., Grize, L., Felix, B., Kraenzlin, M., Henzen, C., & (2022). Determinants of low bone turnover in type 2 diabetes-the role of PTH. Calcif Tissue Int, 111(6), 587–596. https://doi.org/10.1007/s00223-022-01022-7
Charlier, Sarah, Vavanikunnel, Janina, Becker, Claudia, Jick, Susan S., , & Meier, Christoph R. (2021). Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study. Journal of Clinical Endocrinology and Metabolism, 106(2), 554–566. https://doi.org/10.1210/clinem/dgaa796
Charlier, Sarah, Vavanikunnel, Janina, Becker, Claudia, Jick, Susan S., , & Meier, Christoph R. (2021). Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study. Journal of Clinical Endocrinology and Metabolism, 106(2), 554–566. https://doi.org/10.1210/clinem/dgaa796
Tsourdi E, Zillikens MC, , Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, & Langdahl B. (2021). Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS. Journal of Clinical Endocrinology and Metabolism, 106(1), 264–281. https://doi.org/10.1210/clinem/dgaa756
Tsourdi E, Zillikens MC, , Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, & Langdahl B. (2021). Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS. Journal of Clinical Endocrinology and Metabolism, 106(1), 264–281. https://doi.org/10.1210/clinem/dgaa756
Zürcher SJ, Jung R, Monnerat S, Schindera C, Eser P, , Rueegg CS, von der Weid NX, & Kriemler S. (2020). High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit. International Journal of Cancer, 147(7), 1845–1854. https://doi.org/10.1002/ijc.32963
Zürcher SJ, Jung R, Monnerat S, Schindera C, Eser P, , Rueegg CS, von der Weid NX, & Kriemler S. (2020). High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit. International Journal of Cancer, 147(7), 1845–1854. https://doi.org/10.1002/ijc.32963
Ferrari S, Lippuner K, Lamy O, & . (2020). 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss Medical Weekly, 150(3940), w20352. https://doi.org/10.4414/smw.2020.20352
Ferrari S, Lippuner K, Lamy O, & . (2020). 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss Medical Weekly, 150(3940), w20352. https://doi.org/10.4414/smw.2020.20352
Pepe J., Body J.-J., Hadji P., McCloskey E., , Obermayer-Pietsch B., Palermo A., Tsourdi E., Zillikens M.C., Langdahl B., & Ferrari S. (2020). Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF. Journal of Clinical Endocrinology and Metabolism, 105(8), 2487–2506. https://doi.org/10.1210/clinem/dgaa306
Pepe J., Body J.-J., Hadji P., McCloskey E., , Obermayer-Pietsch B., Palermo A., Tsourdi E., Zillikens M.C., Langdahl B., & Ferrari S. (2020). Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF. Journal of Clinical Endocrinology and Metabolism, 105(8), 2487–2506. https://doi.org/10.1210/clinem/dgaa306
Müller F, Appelt KA, , & Suhm N. (2020). Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee. Knee Surgery, Sports Traumatology, Arthroscopy, 28(2), 408–417. https://doi.org/10.1007/s00167-019-05598-w
Müller F, Appelt KA, , & Suhm N. (2020). Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee. Knee Surgery, Sports Traumatology, Arthroscopy, 28(2), 408–417. https://doi.org/10.1007/s00167-019-05598-w
Anastasilakis AD, Tsourdi E, Makras P, Polyzos SA, , McCloskey EV, Pepe J, & Zillikens MC. (2019). Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society. Bone, 127, 401–418. https://doi.org/10.1016/j.bone.2019.07.006
Anastasilakis AD, Tsourdi E, Makras P, Polyzos SA, , McCloskey EV, Pepe J, & Zillikens MC. (2019). Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society. Bone, 127, 401–418. https://doi.org/10.1016/j.bone.2019.07.006
Biver E, Calmy A, & . (2019). Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf (Patent No. 8). Osteoporosis International, 30(8), Article 8. https://doi.org/10.1007/s00198-019-05025-3
Biver E, Calmy A, & . (2019). Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf (Patent No. 8). Osteoporosis International, 30(8), Article 8. https://doi.org/10.1007/s00198-019-05025-3
Biver E, Calmy A, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Ferrari S, Frey D, Kressig RW, Lamy O, Lippuner K, Suhm N, & . (2019). Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis. Osteoporosis International, 30(5), 1125–1135. https://doi.org/10.1007/s00198-018-4794-0
Biver E, Calmy A, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Ferrari S, Frey D, Kressig RW, Lamy O, Lippuner K, Suhm N, & . (2019). Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis. Osteoporosis International, 30(5), 1125–1135. https://doi.org/10.1007/s00198-018-4794-0
Struja T, Jutzi R, Imahorn N, Kaeslin M, Boesiger F, Kutz A, Mundwiler E, Huber A, Kraenzlin M, Mueller B, , Bernasconi L, & Schuetz P. (2019). Comparison of Five TSH-receptor antibody assays in Graves’ disease: Results from an observational pilot study. BMC Endocrine Disorders, 19(1), 38. https://doi.org/10.1186/s12902-019-0363-6
Struja T, Jutzi R, Imahorn N, Kaeslin M, Boesiger F, Kutz A, Mundwiler E, Huber A, Kraenzlin M, Mueller B, , Bernasconi L, & Schuetz P. (2019). Comparison of Five TSH-receptor antibody assays in Graves’ disease: Results from an observational pilot study. BMC Endocrine Disorders, 19(1), 38. https://doi.org/10.1186/s12902-019-0363-6
Ebrahimi, Fahim, Wolffenbuttel, Carole, Blum, Claudine A., Baumgartner, Christine, Mueller, Beat, Schuetz, Philipp, , Kraenzlin, Marius, Christ-Crain, Mirjam, & Betz, Matthias Johannes. (2019). Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials. European Respiratory Journal, 53(2). https://doi.org/10.1183/13993003.00973-2018
Ebrahimi, Fahim, Wolffenbuttel, Carole, Blum, Claudine A., Baumgartner, Christine, Mueller, Beat, Schuetz, Philipp, , Kraenzlin, Marius, Christ-Crain, Mirjam, & Betz, Matthias Johannes. (2019). Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials. European Respiratory Journal, 53(2). https://doi.org/10.1183/13993003.00973-2018
Struja T, Eckart A, Kutz A, Neyer P, Kraenzlin M, Mueller B, , Bernasconi L, & Schuetz P. (2019). Metabolomics and Their Ability to Distinguish Thyroid Disorders: A Retrospective Pilot Study. Hormone and Metabolic Research, 51(4), 256–260. https://doi.org/10.1055/a-0850-9691
Struja T, Eckart A, Kutz A, Neyer P, Kraenzlin M, Mueller B, , Bernasconi L, & Schuetz P. (2019). Metabolomics and Their Ability to Distinguish Thyroid Disorders: A Retrospective Pilot Study. Hormone and Metabolic Research, 51(4), 256–260. https://doi.org/10.1055/a-0850-9691
Vavanikunnel, Janina, Charlier, Sarah, Becker, Claudia, Schneider, Cornelia, Jick, Susan S., Meier, Christoph R., & . (2019). Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study. The Journal of Clinical Endocrinology and Metabolism, 104(5), 1645–1654. https://doi.org/10.1210/jc.2018-01879
Vavanikunnel, Janina, Charlier, Sarah, Becker, Claudia, Schneider, Cornelia, Jick, Susan S., Meier, Christoph R., & . (2019). Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study. The Journal of Clinical Endocrinology and Metabolism, 104(5), 1645–1654. https://doi.org/10.1210/jc.2018-01879
Struja T, Eckart A, Kutz A, Huber A, Neyer P, Kraenzlin M, Mueller B, , Bernasconi L, & Schuetz P. (2018). Metabolomics for prediction of relapse in Graves’ disease: Observational pilot study. Frontiers in Endocrinology, 9(OCT), 623. https://doi.org/10.3389/fendo.2018.00623
Struja T, Eckart A, Kutz A, Huber A, Neyer P, Kraenzlin M, Mueller B, , Bernasconi L, & Schuetz P. (2018). Metabolomics for prediction of relapse in Graves’ disease: Observational pilot study. Frontiers in Endocrinology, 9(OCT), 623. https://doi.org/10.3389/fendo.2018.00623
Refardt, Julie, Farina, Patricia, Hoesli, Irene, & . (2018). Hypercalcemic crisis in third trimenon: evaluating the optimal treatment strategy. Gynecological Endocrinology, 34(10), 833–836. https://doi.org/10.1080/09513590.2018.1462314
Refardt, Julie, Farina, Patricia, Hoesli, Irene, & . (2018). Hypercalcemic crisis in third trimenon: evaluating the optimal treatment strategy. Gynecological Endocrinology, 34(10), 833–836. https://doi.org/10.1080/09513590.2018.1462314
Rueegg CS, Kriemler S, Zuercher SJ, Schindera C, Renner A, Hebestreit H, , Eser P, & von der Weid NX. (2017). A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): Study design of a randomized controlled trial [NCT02730767]. BMC Cancer, 17(1), 822. https://doi.org/10.1186/s12885-017-3801-8
Rueegg CS, Kriemler S, Zuercher SJ, Schindera C, Renner A, Hebestreit H, , Eser P, & von der Weid NX. (2017). A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): Study design of a randomized controlled trial [NCT02730767]. BMC Cancer, 17(1), 822. https://doi.org/10.1186/s12885-017-3801-8
Struja T, Kutz A, Fischli S, , Mueller B, Recher M, & Schuetz P. (2017). Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease. BMC Medicine, 15(1), 174. https://doi.org/10.1186/s12916-017-0939-9
Struja T, Kutz A, Fischli S, , Mueller B, Recher M, & Schuetz P. (2017). Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease. BMC Medicine, 15(1), 174. https://doi.org/10.1186/s12916-017-0939-9
, Uebelhart B, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Frey D, Kressig RW, Lamy O, Lippuner K, Stute P, Suhm N, & Ferrari S. (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO). Swiss Medical Weekly, 147, w14484. https://doi.org/10.4414/smw.2017.14484
, Uebelhart B, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Frey D, Kressig RW, Lamy O, Lippuner K, Stute P, Suhm N, & Ferrari S. (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO). Swiss Medical Weekly, 147, w14484. https://doi.org/10.4414/smw.2017.14484
Gotthardt, Frank, Huber, Christine, Thierfelder, Clara, Grize, Leticia, Kraenzlin, Marius, Scheidegger, Claude, & . (2017). Bone mineral density and its determinants in men with opioid dependence. Journal of Bone and Mineral Metabolism, 35(1), 99–107. https://doi.org/10.1007/s00774-015-0732-9
Gotthardt, Frank, Huber, Christine, Thierfelder, Clara, Grize, Leticia, Kraenzlin, Marius, Scheidegger, Claude, & . (2017). Bone mineral density and its determinants in men with opioid dependence. Journal of Bone and Mineral Metabolism, 35(1), 99–107. https://doi.org/10.1007/s00774-015-0732-9
Struja, Tristan, Kaeslin, Marina, Boesiger, Fabienne, Jutzi, Rebecca, Imahorn, Noemi, Kutz, Alexander, Bernasconi, Luca, Mundwiler, Esther, Mueller, Beat, Christ-Crain, Mirjam, Meienberg, Fabian, Ebrahimi, Fahim, Henzen, Christoph, Fischli, Stefan, Kraenzlin, Marius, , & Schuetz, Philipp. (2017). External validation of the GREAT score to predict relapse risk in Graves’ disease: results from a multicenter, retrospective study with 741 patients. European Journal of Endocrinology, 176(4), 413–419. https://doi.org/10.1530/eje-16-0986
Struja, Tristan, Kaeslin, Marina, Boesiger, Fabienne, Jutzi, Rebecca, Imahorn, Noemi, Kutz, Alexander, Bernasconi, Luca, Mundwiler, Esther, Mueller, Beat, Christ-Crain, Mirjam, Meienberg, Fabian, Ebrahimi, Fahim, Henzen, Christoph, Fischli, Stefan, Kraenzlin, Marius, , & Schuetz, Philipp. (2017). External validation of the GREAT score to predict relapse risk in Graves’ disease: results from a multicenter, retrospective study with 741 patients. European Journal of Endocrinology, 176(4), 413–419. https://doi.org/10.1530/eje-16-0986
Struja, Tristan Mirko, Kutz, Alexander, Fischli, Stefan, , Müller, Beat, & Schütz, Philipp. (2017). Personalised immunomodulating treatments for Graves’ disease: fact or fiction? Swiss Medical Weekly, 147, w14476. https://doi.org/10.4414/smw.2017.14476
Struja, Tristan Mirko, Kutz, Alexander, Fischli, Stefan, , Müller, Beat, & Schütz, Philipp. (2017). Personalised immunomodulating treatments for Graves’ disease: fact or fiction? Swiss Medical Weekly, 147, w14476. https://doi.org/10.4414/smw.2017.14476
Egger A, Kraenzlin ME, & . (2016). Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health. Current Osteoporosis Reports, 14(6), 345–350. https://doi.org/10.1007/s11914-016-0337-9
Egger A, Kraenzlin ME, & . (2016). Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health. Current Osteoporosis Reports, 14(6), 345–350. https://doi.org/10.1007/s11914-016-0337-9
Oranges CM, , & Schaefer DJ. (2016). Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients (Patent No. 3). Plastic and Reconstructive Surgery, 138(3), Article 3. https://doi.org/10.1097/PRS.0000000000002506
Oranges CM, , & Schaefer DJ. (2016). Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients (Patent No. 3). Plastic and Reconstructive Surgery, 138(3), Article 3. https://doi.org/10.1097/PRS.0000000000002506
Spoendlin, Julia, Layton, J. Bradley, Mundkur, Mallika, , Jick, Susan S., & Meier, Christoph R. (2016). New Use of Statins and the Risk of Achilles or Biceps Tendon Rupture: A Propensity-Score Matched Cohort Study. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25, 563.
Spoendlin, Julia, Layton, J. Bradley, Mundkur, Mallika, , Jick, Susan S., & Meier, Christoph R. (2016). New Use of Statins and the Risk of Achilles or Biceps Tendon Rupture: A Propensity-Score Matched Cohort Study. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25, 563.
Egger, A., Kraenzlin, M., & (2016). Osteoporosis and type 2 diabetes. DIABETOLOGE, 12, 254–260. https://doi.org/10.1007/s11428-016-0098-1
Egger, A., Kraenzlin, M., & (2016). Osteoporosis and type 2 diabetes. DIABETOLOGE, 12, 254–260. https://doi.org/10.1007/s11428-016-0098-1
Trombetti A, Christ E.R., Henzen C, Gold G., Brändle M, Herrmann FR, Torriani C, Triponez F, Kraenzlin M, Rizzoli R, & . (2016). Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms. Journal of Endocrinological Investigation, 39(5), 567–576. https://doi.org/10.1007/s40618-015-0423-3
Trombetti A, Christ E.R., Henzen C, Gold G., Brändle M, Herrmann FR, Torriani C, Triponez F, Kraenzlin M, Rizzoli R, & . (2016). Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms. Journal of Endocrinological Investigation, 39(5), 567–576. https://doi.org/10.1007/s40618-015-0423-3
, Schwartz AV, Egger A, & Lecka-Czernik B. (2016). Effects of diabetes drugs on the skeleton. Bone, 82, 93–100. https://doi.org/10.1016/j.bone.2015.04.026
, Schwartz AV, Egger A, & Lecka-Czernik B. (2016). Effects of diabetes drugs on the skeleton. Bone, 82, 93–100. https://doi.org/10.1016/j.bone.2015.04.026
Spoendlin, Julia, Layton, J. Bradley, Mundkur, Mallika, , , Jick, Susan S., & Meier, Christoph R. (2016). The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study. Drug Safety, 39(12), 1229–1237. https://doi.org/10.1007/s40264-016-0462-5
Spoendlin, Julia, Layton, J. Bradley, Mundkur, Mallika, , , Jick, Susan S., & Meier, Christoph R. (2016). The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study. Drug Safety, 39(12), 1229–1237. https://doi.org/10.1007/s40264-016-0462-5
Spoendlin, Julia, , , Jick, Susan S., & Meier, Christoph R. (2016). Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study. Journal of Diabetes and Its Complications, 30(5), 9–903. https://doi.org/10.1016/j.jdiacomp.2016.02.017
Spoendlin, Julia, , , Jick, Susan S., & Meier, Christoph R. (2016). Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study. Journal of Diabetes and Its Complications, 30(5), 9–903. https://doi.org/10.1016/j.jdiacomp.2016.02.017
Suhm N, , Kraenzlin M, Kungler E, Savic B, Mueller S, Jakob M, & Rikli D. (2016). [FLS - three letters alter secondary fracture prevention]. Der Unfallchirurg, 119(1), 7–12. https://doi.org/10.1007/s00113-015-0122-8
Suhm N, , Kraenzlin M, Kungler E, Savic B, Mueller S, Jakob M, & Rikli D. (2016). [FLS - three letters alter secondary fracture prevention]. Der Unfallchirurg, 119(1), 7–12. https://doi.org/10.1007/s00113-015-0122-8
Theiler, R., Freystaetter, G., Platz, A., , & Mellinghoff, H. -U. (2016). Capture the fracture by SMS. Osteologie, 25(4), 283–286. https://doi.org/10.1055/s-0037-1619024
Theiler, R., Freystaetter, G., Platz, A., , & Mellinghoff, H. -U. (2016). Capture the fracture by SMS. Osteologie, 25(4), 283–286. https://doi.org/10.1055/s-0037-1619024
. (2015). Benefits and place of calcimimetics in the management of primary hyperparathyroidism. Annales d’Endocrinologie, 76(2), 163–164. https://doi.org/10.1016/j.ando.2015.03.019
. (2015). Benefits and place of calcimimetics in the management of primary hyperparathyroidism. Annales d’Endocrinologie, 76(2), 163–164. https://doi.org/10.1016/j.ando.2015.03.019
Spoendlin, Julia, , Jick, Susan S, & Meier, Christoph R. (2015). Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study. Annals of Medicine, 47(6), 8–492. https://doi.org/10.3109/07853890.2015.1074272
Spoendlin, Julia, , Jick, Susan S, & Meier, Christoph R. (2015). Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study. Annals of Medicine, 47(6), 8–492. https://doi.org/10.3109/07853890.2015.1074272
, Lamy, Olivier, Krieg, Marc-Antoine, Mellinghoff, Hans-Ulrich, Felder, Markus, Ferrari, Serge, & Rizzoli, Rene. (2014). The role of teriparatide in sequential and combination therapy of osteoporosis. Swiss Medical Weekly, 144. https://doi.org/10.4414/smw.2014.13952
, Lamy, Olivier, Krieg, Marc-Antoine, Mellinghoff, Hans-Ulrich, Felder, Markus, Ferrari, Serge, & Rizzoli, Rene. (2014). The role of teriparatide in sequential and combination therapy of osteoporosis. Swiss Medical Weekly, 144. https://doi.org/10.4414/smw.2014.13952
Stute P, Birkhäuser M, von Wolff M, & . (2014). Gynaecologists’ awareness of bone healthcare in Switzerland. Swiss Medical Weekly, 144, w13931. https://doi.org/10.4414/smw.2014.13931
Stute P, Birkhäuser M, von Wolff M, & . (2014). Gynaecologists’ awareness of bone healthcare in Switzerland. Swiss Medical Weekly, 144, w13931. https://doi.org/10.4414/smw.2014.13931
Kreutle, V., Blum, C., , Past, M., Muller, B., Schutz, P., & Borm, K. (2014). Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature. Swiss Medical Weekly, 144, w13979. https://doi.org/10.4414/smw.2014.13979
Kreutle, V., Blum, C., , Past, M., Muller, B., Schutz, P., & Borm, K. (2014). Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature. Swiss Medical Weekly, 144, w13979. https://doi.org/10.4414/smw.2014.13979
, , Kraenzlin, C, Friederich, N F, Wischer, T, Grize, L, R, & Kraenzlin, M E. (2014). Effect of ibandronate on spontaneous osteonecrosis of the knee : a randomized, double-blind, placebo-controlled trial. Osteoporosis International, 25(1), 66–359. https://doi.org/10.1007/s00198-013-2581-5
, , Kraenzlin, C, Friederich, N F, Wischer, T, Grize, L, R, & Kraenzlin, M E. (2014). Effect of ibandronate on spontaneous osteonecrosis of the knee : a randomized, double-blind, placebo-controlled trial. Osteoporosis International, 25(1), 66–359. https://doi.org/10.1007/s00198-013-2581-5
Nigro N, Christ-Crain M., & . (2014). Testosterone replacement therapy in the aging male - Risks and benefits Hormonersatzbehandlung in der andropause - Nutzen und risiken. Therapeutische Umschau, 71(4), 229–237. https://doi.org/10.1024/0040-5930/a000506
Nigro N, Christ-Crain M., & . (2014). Testosterone replacement therapy in the aging male - Risks and benefits Hormonersatzbehandlung in der andropause - Nutzen und risiken. Therapeutische Umschau, 71(4), 229–237. https://doi.org/10.1024/0040-5930/a000506
Henzen C, Kraenzlin M, & . (2013). [Laboratory investigation of endocrine function - interpretation of results and pitfalls]. Therapeutische Umschau. Revue therapeutique, 70(8), 9–481. https://doi.org/10.1024/0040-5930/a000435
Henzen C, Kraenzlin M, & . (2013). [Laboratory investigation of endocrine function - interpretation of results and pitfalls]. Therapeutische Umschau. Revue therapeutique, 70(8), 9–481. https://doi.org/10.1024/0040-5930/a000435
Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, & . (2013). Intravenous bisphosphonates for postmenopausal osteoporosis: Safety profiles of zoledronic acid and ibandronate in clinical practice. Clinical Drug Investigation, 33(2), 117–122. https://doi.org/10.1007/s40261-012-0041-1
Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, & . (2013). Intravenous bisphosphonates for postmenopausal osteoporosis: Safety profiles of zoledronic acid and ibandronate in clinical practice. Clinical Drug Investigation, 33(2), 117–122. https://doi.org/10.1007/s40261-012-0041-1
, & Kraenzlin ME. (2012). [Osteoporosis: evaluation, diagnosis and monitoring]. Therapeutische Umschau. Revue Therapeutique, 69(3), 52–145. https://doi.org/10.1024/0040-5930/a000267
, & Kraenzlin ME. (2012). [Osteoporosis: evaluation, diagnosis and monitoring]. Therapeutische Umschau. Revue Therapeutique, 69(3), 52–145. https://doi.org/10.1024/0040-5930/a000267
Bodmer, Michael, Becker, Claudia, , , Jick, Susan S., & Meier, Christoph R. (2012). Use of antidiabetic agents and the risk of pancreatic cancer : a case-control analysis. The American Journal of Gastroenterology, 107(4), 620–626. https://doi.org/10.1038/ajg.2011.483
Bodmer, Michael, Becker, Claudia, , , Jick, Susan S., & Meier, Christoph R. (2012). Use of antidiabetic agents and the risk of pancreatic cancer : a case-control analysis. The American Journal of Gastroenterology, 107(4), 620–626. https://doi.org/10.1038/ajg.2011.483
Bodmer, Michael, Becker, Claudia, , , Jick, Susan S., & Meier, Christoph R. (2012). Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis. Cancer Epidemiology Biomarkers & Prevention, 21(2), 280–286. https://doi.org/10.1158/1055-9965.epi-11-0992-t
Bodmer, Michael, Becker, Claudia, , , Jick, Susan S., & Meier, Christoph R. (2012). Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis. Cancer Epidemiology Biomarkers & Prevention, 21(2), 280–286. https://doi.org/10.1158/1055-9965.epi-11-0992-t
Suter-Widmer I, Kraenzlin ME, & . (2011). [Primary hyperparathyroidism]. Therapeutische Umschau. Revue Therapeutique, 68(6), 6–321. https://doi.org/10.1024/0040-5930/a000172
Suter-Widmer I, Kraenzlin ME, & . (2011). [Primary hyperparathyroidism]. Therapeutische Umschau. Revue Therapeutique, 68(6), 6–321. https://doi.org/10.1024/0040-5930/a000172
Bodmer, Michael, Becker, Claudia, , , Jick, Susan S., & Meier, Christoph R. (2011). Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecologic Oncology, 123(2), 200–204. https://doi.org/10.1016/j.ygyno.2011.06.038
Bodmer, Michael, Becker, Claudia, , , Jick, Susan S., & Meier, Christoph R. (2011). Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecologic Oncology, 123(2), 200–204. https://doi.org/10.1016/j.ygyno.2011.06.038
Kraenzlin, Marius E, & . (2011). Parathyroid hormone analogues in the treatment of osteoporosis. Nature Reviews. Endocrinology, 7(11), 56–647. https://doi.org/10.1038/nrendo.2011.108
Kraenzlin, Marius E, & . (2011). Parathyroid hormone analogues in the treatment of osteoporosis. Nature Reviews. Endocrinology, 7(11), 56–647. https://doi.org/10.1038/nrendo.2011.108
, & Kränzlin, Marius E. (2011). Calcium supplementation, osteoporosis and cardiovascular disease. Swiss Medical Weekly, 141, w13260. https://doi.org/10.4414/smw.2011.13260
, & Kränzlin, Marius E. (2011). Calcium supplementation, osteoporosis and cardiovascular disease. Swiss Medical Weekly, 141, w13260. https://doi.org/10.4414/smw.2011.13260
, & Kraenzlin ME. (2011). Antiepileptics and bone health. Therapeutic Advances in Musculoskeletal Disease, 3(5), 235–243. https://doi.org/10.1177/1759720X11410769
, & Kraenzlin ME. (2011). Antiepileptics and bone health. Therapeutic Advances in Musculoskeletal Disease, 3(5), 235–243. https://doi.org/10.1177/1759720X11410769
Suter-Widmer, Isabelle, Kraenzlin, Marius E, & . (2011). Primärer Hyperparathyreoidismus. Therapeutische Umschau, 68(6), 6–321. https://doi.org/10.1024/0040-5930/a000172
Suter-Widmer, Isabelle, Kraenzlin, Marius E, & . (2011). Primärer Hyperparathyreoidismus. Therapeutische Umschau, 68(6), 6–321. https://doi.org/10.1024/0040-5930/a000172
Bodmer, Michael, , , Kraenzlin, Marius E., & Meier, Christoph R. (2010). Proton pump inhibitors and fracture risk: true effect or residual confounding? Drug Safety, 33(10), 52–843. https://doi.org/10.2165/11536780-000000000-00000
Bodmer, Michael, , , Kraenzlin, Marius E., & Meier, Christoph R. (2010). Proton pump inhibitors and fracture risk: true effect or residual confounding? Drug Safety, 33(10), 52–843. https://doi.org/10.2165/11536780-000000000-00000
Bodmer, Michael, , , Krähenbühl, Stephan, Jick, Susan S, & Meier, Christoph R. (2010). Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care, 33(6), 8–1304. https://doi.org/10.2337/dc09-1791
Bodmer, Michael, , , Krähenbühl, Stephan, Jick, Susan S, & Meier, Christoph R. (2010). Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care, 33(6), 8–1304. https://doi.org/10.2337/dc09-1791
Keel, Christina, Kraenzlin, Marius E., Kraenzlin, Claude A., Müller, Beat, & . (2010). Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice. Journal of Bone and Mineral Metabolism, 28(1), 68–76. https://doi.org/10.1007/s00774-009-0101-7
Keel, Christina, Kraenzlin, Marius E., Kraenzlin, Claude A., Müller, Beat, & . (2010). Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice. Journal of Bone and Mineral Metabolism, 28(1), 68–76. https://doi.org/10.1007/s00774-009-0101-7
Kraenzlin, Marius E, Graf, Christian, , Kraenzlin, Claude, & Friedrich, Niklaus F. (2010). Possible beneficial effect of bisphosphonates in osteonecrosis of the knee. Knee Surgery, Sports Traumatology, Arthroscopy, 18(12), 44–1638. https://doi.org/10.1007/s00167-010-1106-4
Kraenzlin, Marius E, Graf, Christian, , Kraenzlin, Claude, & Friedrich, Niklaus F. (2010). Possible beneficial effect of bisphosphonates in osteonecrosis of the knee. Knee Surgery, Sports Traumatology, Arthroscopy, 18(12), 44–1638. https://doi.org/10.1007/s00167-010-1106-4
, Brauchli, Yolanda B, Jick, Susan S, Kraenzlin, Marius E, & Meier, Christoph R. (2010). Use of depot medroxyprogesterone acetate and fracture risk. Journal of clinical endocrinology and metabolism, 95(11), 16–4909. https://doi.org/10.1210/jc.2010-0032
, Brauchli, Yolanda B, Jick, Susan S, Kraenzlin, Marius E, & Meier, Christoph R. (2010). Use of depot medroxyprogesterone acetate and fracture risk. Journal of clinical endocrinology and metabolism, 95(11), 16–4909. https://doi.org/10.1210/jc.2010-0032
Walter, Martin A., , Radimerski, Tanja, Iten, Fabienne, Kränzlin, Marius, Müller-Brand, Jan, de Groot, Jan Willem B., Kema, Ido P., Links, Thera P., & Müller, Beat. (2010). Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer, 116(1), 31–40. https://doi.org/10.1002/cncr.24738
Walter, Martin A., , Radimerski, Tanja, Iten, Fabienne, Kränzlin, Marius, Müller-Brand, Jan, de Groot, Jan Willem B., Kema, Ido P., Links, Thera P., & Müller, Beat. (2010). Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer, 116(1), 31–40. https://doi.org/10.1002/cncr.24738
Richert L, Trombetti A, Herrmann FR, Triponez F, , Robert JH, & Rizzoli R. (2009). Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Medical Weekly, 139(27-28), 400–404. https://doi.org/10.4414/smw.2009.12635
Richert L, Trombetti A, Herrmann FR, Triponez F, , Robert JH, & Rizzoli R. (2009). Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Medical Weekly, 139(27-28), 400–404. https://doi.org/10.4414/smw.2009.12635
, , Bodmer M, R, & Kraenzlin ME. (2009). [Thiazolidinediones and skeletal health]. Revue medicale suisse, 5(207), 1309–1310, 1312–1313.
, , Bodmer M, R, & Kraenzlin ME. (2009). [Thiazolidinediones and skeletal health]. Revue medicale suisse, 5(207), 1309–1310, 1312–1313.
Bodmer, Michael, , , Kraenzlin, Marius E, & Meier, Christoph R. (2009). Risk of fractures with glitazones : a critical review of the evidence to date [Review of Risk of fractures with glitazones : a critical review of the evidence to date]. Drug Safety, 32, Article 7. https://doi.org/10.2165/00002018-200932070-00001
Bodmer, Michael, , , Kraenzlin, Marius E, & Meier, Christoph R. (2009). Risk of fractures with glitazones : a critical review of the evidence to date [Review of Risk of fractures with glitazones : a critical review of the evidence to date]. Drug Safety, 32, Article 7. https://doi.org/10.2165/00002018-200932070-00001
De Geyter, C., Steimann, S., Müller, B., Kränzlin, M. E., & (2009). Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls. Thyroid, 19(1), 9–53. https://doi.org/10.1089/thy.2007.0355
De Geyter, C., Steimann, S., Müller, B., Kränzlin, M. E., & (2009). Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls. Thyroid, 19(1), 9–53. https://doi.org/10.1089/thy.2007.0355
. (2009). [Osteoporosis: diagnostic assessment]. Schweizerische Rundschau Für Medizin Praxis = Revue Suisse de Médecine PRAXIS, 98(20), 7–1141. https://doi.org/10.1024/1661-8157.98.20.1141
. (2009). [Osteoporosis: diagnostic assessment]. Schweizerische Rundschau Für Medizin Praxis = Revue Suisse de Médecine PRAXIS, 98(20), 7–1141. https://doi.org/10.1024/1661-8157.98.20.1141
, Seibel, Markus J, & Kraenzlin, Marius E. (2009). Use of bone turnover markers in the real world: are we there yet? Journal of Bone and Mineral Research : JBMR : The Official Journal of the American Society for Bone and Mineral Research, 24(3), 8–386. https://doi.org/10.1359/jbmr.090104
, Seibel, Markus J, & Kraenzlin, Marius E. (2009). Use of bone turnover markers in the real world: are we there yet? Journal of Bone and Mineral Research : JBMR : The Official Journal of the American Society for Bone and Mineral Research, 24(3), 8–386. https://doi.org/10.1359/jbmr.090104
Richert, Laura, Trombetti, Andrea, Herrmann, François R, Triponez, Frédéric, , Robert, John H, & Rizzoli, René. (2009). Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Medical Weekly : Official Journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology, 139(27-28), 4–400. https://doi.org/smw-12635
Richert, Laura, Trombetti, Andrea, Herrmann, François R, Triponez, Frédéric, , Robert, John H, & Rizzoli, René. (2009). Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Medical Weekly : Official Journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology, 139(27-28), 4–400. https://doi.org/smw-12635
Kränzlin,ME, & . (2008). Prävention der Osteoporose. Ars Medici, 13(5), 581–585.
Kränzlin,ME, & . (2008). Prävention der Osteoporose. Ars Medici, 13(5), 581–585.
, & Kränzlin,ME. (2008). Aromatasehemmer und Osteoporose. Leading Opinons Gynäkologie, 1(4), 14–17.
, & Kränzlin,ME. (2008). Aromatasehemmer und Osteoporose. Leading Opinons Gynäkologie, 1(4), 14–17.
Bodmer, Michael, , Krähenbühl, Stephan, Jick, Susan S, & Meier, Christoph R. (2008). Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia : a nested case-control analysis. Diabetes Care, 31(11), 91–2086. https://doi.org/10.2337/dc08-1171
Bodmer, Michael, , Krähenbühl, Stephan, Jick, Susan S, & Meier, Christoph R. (2008). Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia : a nested case-control analysis. Diabetes Care, 31(11), 91–2086. https://doi.org/10.2337/dc08-1171
Kraenzlin, Marius E., Kraenzlin, Claude A., , Giunta, Cecilia, & Steinmann, Beat. (2008). Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases. Clinical Chemistry, 54(9), 53–1546. https://doi.org/10.1373/clinchem.2008.105262
Kraenzlin, Marius E., Kraenzlin, Claude A., , Giunta, Cecilia, & Steinmann, Beat. (2008). Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases. Clinical Chemistry, 54(9), 53–1546. https://doi.org/10.1373/clinchem.2008.105262
Kränzlin, Marius E., & . (2008). Prävention der Osteoporose. Ars Edici Dossier, Schweizer Zeitschrift Für Hausarztmedizin, 12, 27–31. https://www.rosenfluh.ch/media/arsmedici-dossier/2008/12/Praevention-der-Osteoporose.pdf
Kränzlin, Marius E., & . (2008). Prävention der Osteoporose. Ars Edici Dossier, Schweizer Zeitschrift Für Hausarztmedizin, 12, 27–31. https://www.rosenfluh.ch/media/arsmedici-dossier/2008/12/Praevention-der-Osteoporose.pdf
, Kraenzlin, Marius E., Bodmer, Michael, Jick, Susan S., Jick, Hershel, & Meier, Christoph R. (2008). Use of thiazolidinediones and fracture risk. Archives of Internal Medicine, 168(8), 820–825. https://doi.org/10.1001/archinte.168.8.820
, Kraenzlin, Marius E., Bodmer, Michael, Jick, Susan S., Jick, Hershel, & Meier, Christoph R. (2008). Use of thiazolidinediones and fracture risk. Archives of Internal Medicine, 168(8), 820–825. https://doi.org/10.1001/archinte.168.8.820
, Nguyen, Tuan V, Handelsman, David J, Schindler, Christian, Kushnir, Mark M, Rockwood, Alan L, Meikle, A Wayne, Center, Jacqueline R, Eisman, John A, & Seibel, Markus J. (2008). Endogenous sex hormones and incident fracture risk in older men : the Dubbo Osteoporosis Epidemiology Study. Archives of Internal Medicine, 168(1), 47–54. https://doi.org/10.1001/archinternmed.2007.2
, Nguyen, Tuan V, Handelsman, David J, Schindler, Christian, Kushnir, Mark M, Rockwood, Alan L, Meikle, A Wayne, Center, Jacqueline R, Eisman, John A, & Seibel, Markus J. (2008). Endogenous sex hormones and incident fracture risk in older men : the Dubbo Osteoporosis Epidemiology Study. Archives of Internal Medicine, 168(1), 47–54. https://doi.org/10.1001/archinternmed.2007.2
, & Kränzlin,ME. (2008). Aromatasehemmer und Osteoporose. Leading Opinons. Gynäkologie, 1, 14–17.
, & Kränzlin,ME. (2008). Aromatasehemmer und Osteoporose. Leading Opinons. Gynäkologie, 1, 14–17.
, & Kränzlin,ME. (2008). Therapieoptionen bei postmenopausaler Osteoporose. Gynäkologie, 1, 13–20.
, & Kränzlin,ME. (2008). Therapieoptionen bei postmenopausaler Osteoporose. Gynäkologie, 1, 13–20.
Kraenzlin ME, & . (2007). Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women? Commentary. Nature Clinical Practice Endocrinology and Metabolism, 3(10), 686–687. https://doi.org/10.1038/ncpendmet0618
Kraenzlin ME, & . (2007). Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women? Commentary. Nature Clinical Practice Endocrinology and Metabolism, 3(10), 686–687. https://doi.org/10.1038/ncpendmet0618
Nguyen TV, , Center JR, Eisman JA, & Seibel MJ. (2007). Bone turnover in elderly men: Relationships to change in bone mineral density. BMC Musculoskeletal Disorders, 8, 13. https://doi.org/10.1186/1471-2474-8-13
Nguyen TV, , Center JR, Eisman JA, & Seibel MJ. (2007). Bone turnover in elderly men: Relationships to change in bone mineral density. BMC Musculoskeletal Disorders, 8, 13. https://doi.org/10.1186/1471-2474-8-13
Liu PY, Beilin J, , Nguyen TV, Center JR, Leedman PJ, Seibel MJ, Eisman JA, & Handelsman DJ. (2007). Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: Longitudinal analyses of two geographically separate regional cohorts. Journal of Clinical Endocrinology and Metabolism, 92(9), 3599–3603. https://doi.org/10.1210/jc.2007-0862
Liu PY, Beilin J, , Nguyen TV, Center JR, Leedman PJ, Seibel MJ, Eisman JA, & Handelsman DJ. (2007). Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: Longitudinal analyses of two geographically separate regional cohorts. Journal of Clinical Endocrinology and Metabolism, 92(9), 3599–3603. https://doi.org/10.1210/jc.2007-0862
, Meinhardt U, Greenfield JR, De Winter J, Nguyen TV, Dunstan CR, & Seibel MJ. (2006). Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget’s disease. Clinical Laboratory, 52(1-2), 1–10.
, Meinhardt U, Greenfield JR, De Winter J, Nguyen TV, Dunstan CR, & Seibel MJ. (2006). Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget’s disease. Clinical Laboratory, 52(1-2), 1–10.
Kraenzlin ME, & . (2006). Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer. Expert Opinion on Biological Therapy, 6(2), 167–176. https://doi.org/10.1517/14712598.6.2.167
Kraenzlin ME, & . (2006). Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer. Expert Opinion on Biological Therapy, 6(2), 167–176. https://doi.org/10.1517/14712598.6.2.167
, & Kraenzlin,M.E. (2005). Diagnose und Therapie der postmenopausalen Osteoporose. Z Allgemeinmed, 81(14), 289–302.
, & Kraenzlin,M.E. (2005). Diagnose und Therapie der postmenopausalen Osteoporose. Z Allgemeinmed, 81(14), 289–302.
, Liu PY, Handelsman DJ, & Seibel MJ. (2005). Endocrine regulation of bone turnover in men. Clinical Endocrinology, 63(6), 603–616. https://doi.org/10.1111/j.1365-2265.2005.02333.x
, Liu PY, Handelsman DJ, & Seibel MJ. (2005). Endocrine regulation of bone turnover in men. Clinical Endocrinology, 63(6), 603–616. https://doi.org/10.1111/j.1365-2265.2005.02333.x
, Christ-Crain M, Christoffel-Courtin C, Staub JJ, & Müller B. (2005). Serum estradiol after single dose hCG administration correlates with Leydig cell reserve in hypogonadal men: Reassessment of the hCG stimulation test. Clinical Laboratory, 51(9-10), 509–515.
, Christ-Crain M, Christoffel-Courtin C, Staub JJ, & Müller B. (2005). Serum estradiol after single dose hCG administration correlates with Leydig cell reserve in hypogonadal men: Reassessment of the hCG stimulation test. Clinical Laboratory, 51(9-10), 509–515.
Christ-Crain M, Morgenthaler NG, , Müller C, Nussbaumer C, Bergmann A, Staub JJ, & Müller B. (2005). Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states. Swiss Medical Weekly, 135(37-38), 549–554. https://doi.org/10.4414/smw.2005.11119
Christ-Crain M, Morgenthaler NG, , Müller C, Nussbaumer C, Bergmann A, Staub JJ, & Müller B. (2005). Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states. Swiss Medical Weekly, 135(37-38), 549–554. https://doi.org/10.4414/smw.2005.11119
, Nguyen TV, Center JR, Seibel MJ, & Eisman JA. (2005). Bone resorption and osteoporotic fractures in elderly men: The Dubbo Osteoporosis Epidemiology Study. Journal of Bone and Mineral Research, 20(4), 579–587. https://doi.org/10.1359/JBMR.041207
, Nguyen TV, Center JR, Seibel MJ, & Eisman JA. (2005). Bone resorption and osteoporotic fractures in elderly men: The Dubbo Osteoporosis Epidemiology Study. Journal of Bone and Mineral Research, 20(4), 579–587. https://doi.org/10.1359/JBMR.041207
Lucas GJ, Hocking LJ, Daroszewska A, Cundy T, Nicholson GC, Walsh JP, Fraser WD, , Hooper MJ, & Ralston SH. (2005). Ubiquitin-associated domain mutations of SQSTM1 in Paget’s disease of bone: Evidence for a founder effect in patients of British descent. Journal of Bone and Mineral Research, 20(2), 227–231. https://doi.org/10.1359/JBMR.041106
Lucas GJ, Hocking LJ, Daroszewska A, Cundy T, Nicholson GC, Walsh JP, Fraser WD, , Hooper MJ, & Ralston SH. (2005). Ubiquitin-associated domain mutations of SQSTM1 in Paget’s disease of bone: Evidence for a founder effect in patients of British descent. Journal of Bone and Mineral Research, 20(2), 227–231. https://doi.org/10.1359/JBMR.041106
Christ-Crain, M., , Huber, P. R., Zimmerli, L., & Müller, B. (2005). Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men. Journal of Clinical Endocrinology and Metabolism, 90(3), 6–1280. https://doi.org/10.1210/jc.2004-0850
Christ-Crain, M., , Huber, P. R., Zimmerli, L., & Müller, B. (2005). Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men. Journal of Clinical Endocrinology and Metabolism, 90(3), 6–1280. https://doi.org/10.1210/jc.2004-0850
Christ-Crain,M, , Huber,P.R., Keller,U, Staub,J.J., & Müller,B. (2004). Effect of L-Thyroxine Replacement Therapy on Skeletal and Cardiac Function in Subclinical Hypothyroidism. The Endocrinologist, 14(1616), 6–161.
Christ-Crain,M, , Huber,P.R., Keller,U, Staub,J.J., & Müller,B. (2004). Effect of L-Thyroxine Replacement Therapy on Skeletal and Cardiac Function in Subclinical Hypothyroidism. The Endocrinologist, 14(1616), 6–161.
, Woitge HW, Witte K, Lemmer B, & Seibel MJ. (2004). Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: A randomized controlled open-label prospective trial. Journal of Bone and Mineral Research, 19(8), 1221–1230. https://doi.org/10.1359/JBMR.040511
, Woitge HW, Witte K, Lemmer B, & Seibel MJ. (2004). Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: A randomized controlled open-label prospective trial. Journal of Bone and Mineral Research, 19(8), 1221–1230. https://doi.org/10.1359/JBMR.040511
, & Kränzlin,ME. (2004). Established therapeutic options in postmenopausal osteoporosis Etablierte therapieoptionen bei postmenopausaler osteoporose (Patent No. 2). Journal Fur Mineralstoffwechsel, 11(2), Article 2. https://api.elsevier.com/content/abstract/scopus_id/3042735031
, & Kränzlin,ME. (2004). Established therapeutic options in postmenopausal osteoporosis Etablierte therapieoptionen bei postmenopausaler osteoporose (Patent No. 2). Journal Fur Mineralstoffwechsel, 11(2), Article 2. https://api.elsevier.com/content/abstract/scopus_id/3042735031